Current literature on neuropathies caused by metabolic defects and exogenous toxins is reviewed. Recent work on the molecular basis of hereditary amyloidosis is initially considered followed by various aspects of diabetic neuropathy and then the effects of ciguatoxin and podophyllin on peripheral nerves.